Shares of Ginkgo Bioworks (DNA -10.53%) were sinking 9.5% lower as of 11:34 a.m. ET on Friday. The sell- off came after the biotechnology company announced its fourth-quarter and full-year 2023 results following the market close on Thursday. Ginkgo reported Q4 revenue of $34.8 million, down 65$42.5 million. The company posted a fourth-quarter net loss of $211.7 million, or$0.11 per share. The average analyst estimate was for ...